MBX Biosciences, Profitability Analysis
| MBX Stock | 18.50 1.99 12.05% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -32.6 M | Current Value -34.2 M | Quarterly Volatility 2.6 M |
For MBX Biosciences, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MBX Biosciences, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MBX Biosciences, Common utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MBX Biosciences,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MBX Biosciences, Common over time as well as its relative position and ranking within its peers.
MBX |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MBX Biosciences,. If investors know MBX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MBX Biosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) |
The market value of MBX Biosciences, Common is measured differently than its book value, which is the value of MBX that is recorded on the company's balance sheet. Investors also form their own opinion of MBX Biosciences,'s value that differs from its market value or its book value, called intrinsic value, which is MBX Biosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MBX Biosciences,'s market value can be influenced by many factors that don't directly affect MBX Biosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MBX Biosciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MBX Biosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MBX Biosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MBX Biosciences, Common Shares Outstanding vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining MBX Biosciences,'s current stock value. Our valuation model uses many indicators to compare MBX Biosciences, value to that of its competitors to determine the firm's financial worth. MBX Biosciences, Common is rated top company in current valuation category among its peers. It is rated below average in shares outstanding category among its peers creating about 0.05 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for MBX Biosciences, Common is roughly 19.27 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MBX Biosciences,'s earnings, one of the primary drivers of an investment's value.MBX Current Valuation vs. Competition
MBX Biosciences, Common is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 1.17 Billion. MBX Biosciences, totals roughly 613.91 Million in current valuation claiming about 53% of equities under Health Care industry.
MBX Shares Outstanding vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
MBX Biosciences, |
| = | 613.91 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
MBX Biosciences, |
| = | 31.85 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
MBX Shares Outstanding Comparison
MBX Biosciences, is currently under evaluation in shares outstanding category among its peers.
MBX Biosciences, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in MBX Biosciences,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MBX Biosciences, will eventually generate negative long term returns. The profitability progress is the general direction of MBX Biosciences,'s change in net profit over the period of time. It can combine multiple indicators of MBX Biosciences,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 2.7 M | 1.5 M | |
| Interest Income | 2.7 M | 1.7 M | |
| Operating Income | -35.3 M | -37.1 M | |
| Net Loss | -32.6 M | -34.2 M | |
| Income Before Tax | -32.6 M | -34.2 M | |
| Total Other Income Expense Net | -874.8 K | -918.5 K | |
| Net Loss | -32.6 M | -34.2 M |
MBX Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on MBX Biosciences,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MBX Biosciences, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MBX Biosciences,'s important profitability drivers and their relationship over time.
MBX Biosciences, Profitability Trends
MBX Biosciences, profitability trend refers to the progression of profit or loss within a business. An upward trend means that MBX Biosciences,'s profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is MBX Biosciences,'s gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.
MBX Biosciences, Profitability Drivers Correlations
One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between MBX Biosciences, different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards MBX Biosciences, in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down MBX Biosciences,'s future profitability.
Click cells to compare fundamentals
Use MBX Biosciences, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MBX Biosciences, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MBX Biosciences, will appreciate offsetting losses from the drop in the long position's value.MBX Biosciences, Pair Trading
MBX Biosciences, Common Pair Trading Analysis
The ability to find closely correlated positions to MBX Biosciences, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MBX Biosciences, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MBX Biosciences, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MBX Biosciences, Common to buy it.
The correlation of MBX Biosciences, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MBX Biosciences, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MBX Biosciences, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MBX Biosciences, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your MBX Biosciences, position
In addition to having MBX Biosciences, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run FinTech Thematic Idea Now
FinTech
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 81 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for MBX Stock Analysis
When running MBX Biosciences,'s price analysis, check to measure MBX Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences, is operating at the current time. Most of MBX Biosciences,'s value examination focuses on studying past and present price action to predict the probability of MBX Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences,'s price. Additionally, you may evaluate how the addition of MBX Biosciences, to your portfolios can decrease your overall portfolio volatility.